Is it safe?
Can MAZE take a bad year?
Maze Therapeutics, Inc. holds $372M more cash than debt, and is burning $27M a quarter, about 3.9 years of cover.
$372M
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Cash runway
- 3.9 years
Cash runway · burning $27M a quarter at the current rate
- Annualised volatility
- 91%
Annualised volatility · three times the market's own swing
Details›
- Total debtQ2 2026
- $39M
- Cash and short-term investments
- $411M
- Net cash
- $372M
- EBITDA, trailing twelve months
- −$144M
- Operating profit, trailing twelve months
- −$146M
- Debt / equity
- 0.09×
- Annualised volatilitytwo years of daily moves
- 91%
- Worst drawdown on file
- −55%
- Below its 52-week high
- −43%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.